Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.625 USD | +1.69% | +1.05% | +83.42% |
May. 09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.42% | 10.73M | |
+64.40% | 62.59B | |
-1.98% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.43% | 26.21B | |
-22.14% | 19.09B | |
+3.84% | 13.08B | |
+25.49% | 12.26B | |
+27.17% | 12.05B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics Gets Clearance to Start Phase 1 Trial in Advanced Cancers in Australia